Respiratory sarcopenia and sarcopenic respiratory disability: concepts, diagnosis, and treatment
A Nagano, H Wakabayashi, K Maeda, Y Kokura… - The journal of nutrition …, 2021 - Springer
The condition of muscle fiber atrophy and weakness that occurs in respiratory muscles along
with systemic skeletal muscle with age is known as respiratory sarcopenia. The Japanese …
with systemic skeletal muscle with age is known as respiratory sarcopenia. The Japanese …
Respiratory sarcopenia: a position paper by four professional organizations
S Sato, S Miyazaki, A Tamaki… - Geriatrics & …, 2023 - Wiley Online Library
We defined respiratory sarcopenia as a coexistence of respiratory muscle weakness and
decreased respiratory muscle mass. Although respiratory muscle function is indispensable …
decreased respiratory muscle mass. Although respiratory muscle function is indispensable …
Muscle quality is more impaired in sarcopenic patients with chronic obstructive pulmonary disease
C van de Bool, HR Gosker, B van den Borst… - Journal of the American …, 2016 - Elsevier
Background Quadriceps muscle fiber atrophy and a loss of oxidative type I muscle fibers and
mitochondrial content often occur in chronic obstructive pulmonary disease (COPD), which …
mitochondrial content often occur in chronic obstructive pulmonary disease (COPD), which …
Osteosarcopenia in patients with chronic obstructive pulmonary diseases: which pathophysiologic implications for rehabilitation?
L Lippi, A Folli, C Curci, F D'Abrosca, S Moalli… - International Journal of …, 2022 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is a burdensome condition affecting a
growing number of people worldwide, frequently related to major comorbidities and …
growing number of people worldwide, frequently related to major comorbidities and …
The 2014 ESPEN Arvid Wretlind Lecture: metabolism & nutrition: shifting paradigms in COPD management
AMWJ Schols - Clinical Nutrition, 2015 - Elsevier
COPD is a chronic disease of the lungs, but heterogeneous with respect to clinical
manifestations and disease progression. This has consequences for health risk assessment …
manifestations and disease progression. This has consequences for health risk assessment …
The pathophysiology of cachexia in chronic obstructive pulmonary disease
AMWJ Schols, HR Gosker - Current opinion in supportive and …, 2009 - journals.lww.com
Recent translational approaches have clearly advanced our understanding of the
pathophysiology of cachexia in COPD. Although this complex clinical syndrome may clearly …
pathophysiology of cachexia in COPD. Although this complex clinical syndrome may clearly …
Muscle dysfunction associated with chronic obstructive pulmonary disease
NR Macintyre - Respiratory care, 2006 - rc.rcjournal.com
Skeletal-muscle (both respiratory and limb) abnormalities are common and can have
profound effects in patients with chronic inflammatory states such as chronic obstructive …
profound effects in patients with chronic inflammatory states such as chronic obstructive …
Factors contributing to muscle wasting and dysfunction in COPD patients
Many patients with chronic obstructive pulmonary disease (COPD) suffer from exercise
intolerance. In about 40% of the patients exercise capacity is limited by alterations in skeletal …
intolerance. In about 40% of the patients exercise capacity is limited by alterations in skeletal …
Gene polymorphisms associated with heterogeneity and senescence characteristics of sarcopenia in chronic obstructive pulmonary disease
Background Sarcopenia, or loss of skeletal muscle mass and decreased contractile strength,
contributes to morbidity and mortality in patients with chronic obstructive pulmonary disease …
contributes to morbidity and mortality in patients with chronic obstructive pulmonary disease …
Possible mechanisms underlying the development of cachexia in COPD
PD Wagner - European Respiratory Journal, 2008 - Eur Respiratory Soc
About 25% of patients with chronic obstructive pulmonary disease (COPD) will develop
cachexia (fat-free body mass index< 17 kg· m− 2 (males) or< 14 kg· m− 2 (females)). This is …
cachexia (fat-free body mass index< 17 kg· m− 2 (males) or< 14 kg· m− 2 (females)). This is …